#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis gene carrier Chronic cutaneous lupus erythematosus Gastrointestinal neuroendocrine tumour Rhabdoid tumour Lupus nephritis Fragile X syndrome Ependymoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Transient ischaemic attack Thalassaemia alpha Non-small cell lung cancer recurrent Obesity Type IIa hyperlipidaemia Ocular myasthenia Kidney transplant rejection More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Trials in Disease Biotinidase deficiency – Basic Information Lymphangioma – Treatment Leiomyosarcoma metastatic – Life with Disease Thrombotic thrombocytopenic purpura – Diagnostics Osteosarcoma metastatic – Diagnostics Rett syndrome – Treatment Haemophilia A with anti factor VIII – Trials in Disease Splenic marginal zone lymphoma – Life with Disease Myxofibrosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paclitaxel ARTICAINE HYDROCHLORIDE Golexanolone Water For Injections Clascoterone Mifamurtide Salmeterol Xinafoate GSK5458514 Infliximab Olanzapine AP31969 SULFATE Olmesartan Medoxomil Benzylpenicillin Argon Pelacarsen Glepaglutide Glibenclamide Levocarnitine Toripalimab Insulin Aspart More therapies…

    Learn about Your Condition

    Cardiac ventricular thrombosis Circulatory collapse Normal pressure hydrocephalus Peyronie's disease Urinary incontinence Morning sickness Brain neoplasm malignant Connective tissue disorder Haemophilia Hepatobiliary disease Endometrial cancer Endotracheal intubation Graves' disease Colorectal cancer Primary myelofibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gastric cancer

  • Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to biliary tract
    • Metastases to central nervous system
    • Metastatic glioma
    Investigated Drugs:
    • 6-Fluoro-5-[4-[(5-Fluoro-2-Methyl-3-Oxo-4H-Quinoxalin-6-Yl)Methyl]Piperazin-1-Yl]-N-Methylpyridine-2-Carboxamide
    • [11C]Az14193391
    • Temozolomide
    Spain Sweden

  • Study on Trastuzumab Deruxtecan and Fluorouracil for Patients with HER2-Positive Gastric or Gastroesophageal Cancer with Minimal Residual Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Gastric cancer
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Calcium Folinate
    • Capecitabine
    Italy

  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Breast cancer recurrent
    • Breast cancer stage IV
    Investigated Drugs:
    • Ds-3939A
    Belgium France Spain

  • Immune Modulation Study of Rilvegostomig and Pembrolizumab in Patients with Advanced Gastric Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Rilvegostomig
    • Pembrolizumab
    Spain

  • Capecitabine drug combination in perioperative treatment for patients with gastric and esophageal cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Capecitabine
    The Netherlands

  • Diagnostic Accuracy of [18F]FAPI-74 PET/CT for Detecting Metastasis and Assessing Treatment Response in Gastric Cancer Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Finland
Previous Page
1 2 3 4 5 6 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!